Mark G. Foletta

Mark G. Foletta (board member) discloses dealings in 2 companies, chiefly Dexcom Inc and AMN Healthcare Services Inc. Over a trading history stretching from 20 May 2021 to 3 August 2026, the count stands at 29 filings.

Market trades split into 1 purchase (€26k) and 16 sales (€1.6M). The totals exclude 4 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 6 sales.

Most recently, on 4 August 2026, the filings show an open-market sale worth €139k in Dexcom Inc. The last purchase on record was published on 1 March 2024, which is 961 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.